Literature DB >> 24016497

Prognostic importance of coronary anatomy and left ventricular ejection fraction despite optimal therapy: assessment of residual risk in the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation Trial.

G B John Mancini1, Pamela M Hartigan, Eric R Bates, Bernard R Chaitman, Steven P Sedlis, David J Maron, William J Kostuk, John A Spertus, Koon K Teo, Marcin Dada, Merril Knudtson, Daniel S Berman, David C Booth, William E Boden, William S Weintraub.   

Abstract

BACKGROUND: It is unknown if baseline angiographic findings can be used to estimate residual risk of patients with chronic stable angina treated with both optimal medical therapy (OMT) and protocol-assigned or symptom-driven percutaneous coronary intervention (PCI).
METHODS: Death, myocardial infarction (MI), and hospitalization for non-ST-segment elevation acute coronary syndrome were adjudicated in 2,275 COURAGE patients. The number of vessels diseased (VD) was defined as the number of major coronary arteries with ≥50% diameter stenosis. Proximal left anterior descending, either isolated or in combination with other disease, was also evaluated. Depressed left ventricular ejection fraction (LVEF) was defined as ≤50%. Cox regression analyses included these anatomical factors as well as interaction terms for initial treatment assignment (OMT or OMT + PCI).
RESULTS: Percutaneous coronary intervention and proximal left anterior descending did not influence any outcome. Death was predicted by low LVEF (hazard ratio [HR] 1.86, CI 1.34-2.59, P < .001) and VD (HR 1.45, CI 1.20-1.75, P < .001). Myocardial infarction and non-ST-segment elevation acute coronary syndrome were predicted only by VD (HR 1.53, CI 1.30-1.81 and HR 1.24, CI 1.06-1.44, P = .007, respectively).
CONCLUSIONS: In spite of OMT and irrespective of protocol-assigned or clinically driven PCI, LVEF and angiographic burden of disease at baseline retain prognostic power and reflect residual risk for secondary ischemic events.
© 2013.

Entities:  

Mesh:

Year:  2013        PMID: 24016497     DOI: 10.1016/j.ahj.2013.07.007

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  9 in total

Review 1.  Current Indications for Stenting: Symptoms or Survival CME.

Authors:  Suzanne V Arnold
Journal:  Methodist Debakey Cardiovasc J       Date:  2018 Jan-Mar

Review 2.  Role of Fractional-Flow Reserve in Guiding Percutaneous Revascularization in Stable Coronary Artery Disease.

Authors:  Nikolaos Kakouros; Jeffrey J Rade
Journal:  Curr Atheroscler Rep       Date:  2015-09       Impact factor: 5.113

Review 3.  Challenges with Evidence-Based Management of Stable Ischemic Heart Disease.

Authors:  Amit V Patel; Sripal Bangalore
Journal:  Curr Cardiol Rep       Date:  2017-02       Impact factor: 2.931

4.  Effect of PCI on Long-Term Survival in Patients with Stable Ischemic Heart Disease.

Authors:  Steven P Sedlis; Pamela M Hartigan; Koon K Teo; David J Maron; John A Spertus; G B John Mancini; William Kostuk; Bernard R Chaitman; Daniel Berman; Jeffrey D Lorin; Marcin Dada; William S Weintraub; William E Boden
Journal:  N Engl J Med       Date:  2015-11-12       Impact factor: 91.245

5.  In-hospital measurement of left ventricular ejection fraction and one-year outcomes in acute coronary syndromes: results from the IMMEDIATE Trial.

Authors:  Jayanta T Mukherjee; Joni R Beshansky; Robin Ruthazer; Hadeel Alkofide; Madhab Ray; David Kent; Warren J Manning; Gordon S Huggins; Harry P Selker
Journal:  Cardiovasc Ultrasound       Date:  2016-08-03       Impact factor: 2.062

Review 6.  Harmonizing the Paradigm With the Data in Stable Coronary Artery Disease: A Review and Viewpoint.

Authors:  Joshua D Mitchell; David L Brown
Journal:  J Am Heart Assoc       Date:  2017-11-13       Impact factor: 5.501

7.  Coronary revascularization vs. medical therapy following coronary-computed tomographic angiography in patients with low-, intermediate- and high-risk coronary artery disease: results from the CONFIRM long-term registry.

Authors:  Joshua Schulman-Marcus; Fay Y Lin; Heidi Gransar; Daniel Berman; Tracy Callister; Augustin DeLago; Martin Hadamitzky; Joerg Hausleiter; Mouaz Al-Mallah; Matthew Budoff; Philipp Kaufmann; Stephan Achenbach; Gilbert Raff; Kavitha Chinnaiyan; Filippo Cademartiri; Erica Maffei; Todd Villines; Yong-Jin Kim; Jonathon Leipsic; Gudrun Feuchtner; Ronen Rubinshtein; Gianluca Pontone; Daniele Andreini; Hugo Marques; Hyuk-Jae Chang; Benjamin J W Chow; Ricardo C Cury; Allison Dunning; Leslee Shaw; James K Min
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2017-05-01       Impact factor: 6.875

8.  Do athletes play by different rules? Obstructive coronary artery disease in asymptomatic competitive Masters athletes: a case series.

Authors:  James McKinney; Nathaniel Moulson; Barbara N Morrison; Jobanjit S Phulka; Phillip Yeung; Saul Isserow; David A Wood
Journal:  Eur Heart J Case Rep       Date:  2020-03-26

9.  High cardiovascular risk of patients with type 2 diabetes is only partially attributed to angiographic burden of atherosclerosis.

Authors:  Simone Battermann; Andrea Milzi; Rosalia Dettori; Kathrin Burgmaier; Nikolaus Marx; Mathias Burgmaier; Sebastian Reith
Journal:  Diab Vasc Dis Res       Date:  2020 Sep-Oct       Impact factor: 3.291

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.